标题
The emerging roles of HDACs and their therapeutic implications in cancer
作者
关键词
-
出版物
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 931, Issue -, Pages 175216
出版商
Elsevier BV
发表日期
2022-08-18
DOI
10.1016/j.ejphar.2022.175216
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Molecular mechanisms of transgenerational epigenetic inheritance
- (2022) Maximilian H. Fitz-James et al. NATURE REVIEWS GENETICS
- Overview of SIRT5 as a potential therapeutic target: Structure, function and inhibitors
- (2022) Yingying Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- PGC1α-mediated fatty acid oxidation promotes TGFβ1-induced epithelial-mesenchymal transition and metastasis of nasopharyngeal carcinoma
- (2022) Jing Quan et al. LIFE SCIENCES
- SIRT3-Mediated SOD2 and PGC-1α Contribute to Chemoresistance in Colorectal Cancer Cells
- (2021) Masakatsu Paku et al. ANNALS OF SURGICAL ONCOLOGY
- HDAC5 loss impairs RB repression of pro-oncogenic genes and confers CDK4/6 inhibitor resistance in cancer
- (2021) Yingke Zhou et al. CANCER RESEARCH
- Sirt1 deacetylates and stabilizes p62 to promote hepato-carcinogenesis
- (2021) Lifeng Feng et al. Cell Death & Disease
- Tumor suppressive role of mitochondrial sirtuin 4 in induction of G2/M cell cycle arrest and apoptosis in hepatitis B virus-related hepatocellular carcinoma
- (2021) Fung-Yu Huang et al. Cell Death Discovery
- Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression
- (2021) Tuo Hu et al. GASTROENTEROLOGY
- MiR-342-3p inhibits LCSC oncogenicity and cell stemness through HDAC7/PTEN axis
- (2021) Chunlin Xu et al. INFLAMMATION RESEARCH
- Histone Acetyltransferases and Deacetylases Are Required for Virulence, Conidiation, DNA Damage Repair, and Multiple Stresses Resistance of Alternaria alternata
- (2021) Haijie Ma et al. Frontiers in Microbiology
- Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer
- (2021) Bingyi Zhou et al. Frontiers in Cell and Developmental Biology
- SIRT 2‐dependent IDH 1 deacetylation inhibits colorectal cancer and liver metastases
- (2020) Bo Wang et al. EMBO REPORTS
- HDAC1 and HDAC2 regulate anti‐inflammatory effects of anesthetic isoflurane in human monocytes
- (2020) Xinying Guo et al. IMMUNOLOGY AND CELL BIOLOGY
- Quinacrine causes apoptosis in human cancer cell lines through caspase-mediated pathway and regulation of small-GTPase
- (2020) Angela Samanta et al. JOURNAL OF BIOSCIENCES
- Inhibition of JNJ-26481585-mediated autophagy induces apoptosis via ROS activation and mitochondrial membrane potential disruption in neuroblastoma cells
- (2020) Vamsi Krishna Kommalapati et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Role of HDACs in normal and malignant hematopoiesis
- (2020) Pan Wang et al. Molecular Cancer
- HDAC8 cooperates with SMAD3/4 complex to suppress SIRT7 and promote cell survival and migration
- (2020) Xiaolong Tang et al. NUCLEIC ACIDS RESEARCH
- Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2
- (2020) Namrata Bora-Singhal et al. Scientific Reports
- Sirt3 Exerts Its Tumor-Suppressive Role by Increasing p53 and Attenuating Response to Estrogen in MCF-7 Cells
- (2020) Marija Pinterić et al. Antioxidants
- Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells
- (2020) Imene Hamaidi et al. Cell Metabolism
- Synergy between SIRT1 and SIRT6 helps recognize DNA breaks and potentiates the DNA damage response and repair in humans and mice
- (2020) Fanbiao Meng et al. eLife
- SirT7 auto-ADP-ribosylation regulates glucose starvation response through mH2A1
- (2020) Nicolás G. Simonet et al. Science Advances
- Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease
- (2020) Linda Anna Michelle Kulka et al. Frontiers in Cell and Developmental Biology
- Promoter Hypomethylation and miR-145-5p Downregulation- Mediated HDAC11 Overexpression Promotes Sorafenib Resistance and Metastasis of Hepatocellular Carcinoma Cells
- (2020) Wenlong Wang et al. Frontiers in Cell and Developmental Biology
- Sirtuin 5 regulates the proliferation, invasion and migration of prostate cancer cells through acetyl‐CoA acetyltransferase 1
- (2020) Jingqian Guan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- HDAC9 Is Preferentially Expressed in Dedifferentiated Hepatocellular Carcinoma Cells and Is Involved in an Anchorage-Independent Growth
- (2020) Keita Kanki et al. Cancers
- Subcellular Localization and Mitotic Interactome Analyses Identify SIRT4 as a Centrosomally Localized and Microtubule Associated Protein
- (2020) Laura Bergmann et al. Cells
- SIRT4 is the molecular switch mediating cellular proliferation in colorectal cancer through GLS mediated activation of AKT/GSK3β/Cyclin D1 pathway
- (2020) Ying Cui et al. CARCINOGENESIS
- Role of Altered Expression, Activity and Sub-cellular Distribution of Various Histone Deacetylases (HDACs) in Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis
- (2020) Arpna Srivastava et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma
- (2020) Ruixue Zhang et al. Cell Death & Disease
- CD13 promotes hepatocellular carcinogenesis and sorafenib resistance by activating HDAC5‐LSD1‐NF‐κB oncogenic signaling
- (2020) Bo Hu et al. Clinical and Translational Medicine
- Targeting post-translational histone modifying enzymes in glioblastoma
- (2020) Elena Kunadis et al. PHARMACOLOGY & THERAPEUTICS
- Sirtuins' control of autophagy and mitophagy in cancer
- (2020) Michele Aventaggiato et al. PHARMACOLOGY & THERAPEUTICS
- SIRT4 regulates PTEN stability through IDE in response to cellular stresses
- (2019) Minghui Liu et al. FASEB JOURNAL
- The Roles of Mitochondrial SIRT4 in Cellular Metabolism
- (2019) Zheying Min et al. Frontiers in Endocrinology
- SIRT4 inhibits the proliferation, migration, and invasion abilities of thyroid cancer cells by inhibiting glutamine metabolism
- (2019) Zhouxun Chen et al. OncoTargets and Therapy
- HDAC11 regulates type I interferon signaling through defatty-acylation of SHMT2
- (2019) Ji Cao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer
- (2019) Qiangsheng Hu et al. CANCER LETTERS
- SIRT5 downregulation is associated with poor prognosis in glioblastoma
- (2019) Xi Chen et al. Cancer Biomarkers
- Posttranslational modifications and proteinopathies: how guardians of the proteome are defeated
- (2019) Heidi Olzscha BIOLOGICAL CHEMISTRY
- SIRT5-mediated SDHA desuccinylation promotes clear cell renal cell carcinoma tumorigenesis
- (2019) Yuanzhen Ma et al. FREE RADICAL BIOLOGY AND MEDICINE
- MKK7 transcription positively or negatively regulated by SP1 and KLF5 depends on HDAC4 activity in glioma
- (2019) Yezhong Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Histone deacetylase 9 downregulation decreases tumor growth and promotes apoptosis in NSCLC after melatonin treatment
- (2019) Zhiqiang Ma et al. JOURNAL OF PINEAL RESEARCH
- SIRT1 deacetylated and stabilized XRCC1 to promote chemoresistance in lung cancer
- (2019) Neelum Aziz Yousafzai et al. Cell Death & Disease
- Histone Deacetylase Inhibitors Sensitize TRAIL-Induced Apoptosis in Colon Cancer Cells
- (2019) Baojie Zhang et al. Cancers
- Anti-metastatic activity of MPT0G211, a novel HDAC6 inhibitor, in human breast cancer cells in vitro and in vivo
- (2019) Yi-Ling Hsieh et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Phase 1–2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B‐cell non‐Hodgkin lymphoma and previously untreated mantle cell lymphoma
- (2019) Stephen E. Spurgeon et al. BRITISH JOURNAL OF HAEMATOLOGY
- OGDH mediates the inhibition of SIRT5 on cell proliferation and migration of gastric cancer
- (2019) Xin Lu et al. EXPERIMENTAL CELL RESEARCH
- The Role of SIRT1 on DNA Damage Response and Epigenetic Alterations in Cancer
- (2019) Débora Kristina Alves-Fernandes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SENP1-Sirt3 Signaling Controls Mitochondrial Protein Acetylation and Metabolism
- (2019) Tianshi Wang et al. MOLECULAR CELL
- Dopamine receptor antagonists as potential therapeutic agents for ADPKD
- (2019) Parama Paul et al. PLoS One
- 4-hydroxyphenylpyruvate dioxygenase promotes lung cancer growth via pentose phosphate pathway (PPP) flux mediated by LKB1-AMPK/HDAC10/G6PD axis
- (2019) Changliang Shan et al. Cell Death & Disease
- Promoter conservation in HDACs points to functional implications
- (2019) Toni A. Boltz et al. BMC GENOMICS
- Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non–Small Cell Lung Cancer
- (2019) Jhanelle E. Gray et al. CLINICAL CANCER RESEARCH
- The Histone Deacetylase SIRT6 Restrains Transcription Elongation via Promoter-Proximal Pausing
- (2019) Jean-Pierre Etchegaray et al. MOLECULAR CELL
- The emerging role of epigenetic therapeutics in immuno-oncology
- (2019) Michael J. Topper et al. Nature Reviews Clinical Oncology
- SIRT6, a Mammalian deacylase with multitasking abilities
- (2019) Andrew R Chang et al. PHYSIOLOGICAL REVIEWS
- Cigarette smoke extract modulates Pseudomonas aeruginosa bacterial load via USP25/HDAC11 axis in lung epithelial cells
- (2019) Chen Long et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- SIRT1 and p300/CBP regulate the reversible acetylation of serine-threonine kinase NDR2
- (2019) Yunlan Tang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Valproic acid targets HDAC1/2 and HDAC1/PTEN/Akt signalling to inhibit cell proliferation via the induction of autophagy in gastric cancer
- (2019) Jie Sun et al. FEBS Journal
- Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells
- (2019) Dipankar Ray et al. GASTROENTEROLOGY
- Histone deacetylases in virus‐associated cancers
- (2019) Habibollah Mirzaei et al. REVIEWS IN MEDICAL VIROLOGY
- Histone deacetylase 11 inhibition promotes breast cancer metastasis from lymph nodes
- (2019) Patrick L. Leslie et al. Nature Communications
- Evodiamine-inspired dual inhibitors of histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) with potent antitumor activity
- (2019) Yahui Huang et al. Acta Pharmaceutica Sinica B
- Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
- (2019) Kim Freese et al. Cancers
- HDAC Inhibitors in Acute Myeloid Leukemia
- (2019) San José-Enériz et al. Cancers
- HDAC4 Levels Control Sensibility toward Cisplatin in Gastric Cancer via the p53-p73/BIK Pathway
- (2019) Marie-Elodie Spaety et al. Cancers
- The Development Process: from SAHA to Hydroxamate HDAC Inhibitors with Branched CAP Region and Linear Linker
- (2019) Feifei Yang et al. CHEMISTRY & BIODIVERSITY
- Control of Lymphocyte Fate, Infection, and Tumor Immunity by TCF-1
- (2019) Dinesh Raghu et al. TRENDS IN IMMUNOLOGY
- HDAC3 maintains oocyte meiosis arrest by repressing amphiregulin expression before the LH surge
- (2019) Huarong Wang et al. Nature Communications
- Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming
- (2018) Agnes L.C. Ong et al. AGEING RESEARCH REVIEWS
- SIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection
- (2018) Nunzia D'Onofrio et al. ANTIOXIDANTS & REDOX SIGNALING
- HDAC6 interacts with PTPN1 to enhance melanoma cells progression
- (2018) Jiaqi Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- HDAC11 is a regulator of diverse immune functions
- (2018) Cansu Yanginlar et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- HDACis (class I), cancer stem cell, and phytochemicals: Cancer therapy and prevention implications
- (2018) Sahar Bayat et al. BIOMEDICINE & PHARMACOTHERAPY
- The role of histone deacetylase 1 in distant metastasis of pancreatic ductal cancer
- (2018) Go Shinke et al. CANCER SCIENCE
- Regulation of Apoptosis and Radiation Sensitization in Lung Cancer Cells via the Sirt1/NF-κB/Smac Pathway
- (2018) Kaihua Ji et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology
- (2018) Surinder Kumar et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- The epigenetic regulator SIRT7 guards against mammalian cellular senescence induced by ribosomal DNA instability
- (2018) Silvana Paredes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Combination Therapies Targeting HDAC and IKK in Solid Tumors
- (2018) Ivana Vancurova et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- SIRT4 acts as a tumor suppressor in gastric cancer by inhibiting cell proliferation, migration, and invasion
- (2018) Hongjie Sun et al. OncoTargets and Therapy
- Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy
- (2018) Amit Singh et al. Nutrients
- Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
- (2018) Amila Suraweera et al. Frontiers in Oncology
- HDAC1 Silencing in Ovarian Cancer Enhances the Chemotherapy Response
- (2018) Xinfeng Liu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches
- (2018) Nilanjan Adhikari et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- SIRT3 Overexpression Inhibits Growth of Kidney Tumor Cells and Enhances Mitochondrial Biogenesis
- (2018) Huan Liu et al. JOURNAL OF PROTEOME RESEARCH
- SIRT5-mediated deacetylation of LDHB promotes autophagy and tumorigenesis in colorectal cancer
- (2018) Liang Shi et al. Molecular Oncology
- Functions and mechanisms of non-histone protein acetylation
- (2018) Takeo Narita et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Histone deacetylase 6 expression in metastatic lymph nodes is a valuable prognostic marker for resected node-positive esophageal squamous cell cancer
- (2018) Xuan Xie et al. Cancer Management and Research
- HDAC10 as a potential therapeutic target in ovarian cancer
- (2017) Muhtadi M. Islam et al. GYNECOLOGIC ONCOLOGY
- Histone Deacetylase Inhibitor-Induced Autophagy in Tumor Cells: Implications for p53
- (2017) Maria Mrakovcic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sirtuin 2 mutations in human cancers impair its function in genome maintenance
- (2017) PamelaSara E. Head et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SirT3 and p53 Deacetylation in Aging and Cancer
- (2017) Jijun Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications
- (2017) T Harada et al. LEUKEMIA
- Low SIRT3 expression contributes to tumor progression, development and poor prognosis in human pancreatic carcinoma
- (2017) Shanshan Huang et al. PATHOLOGY RESEARCH AND PRACTICE
- Histone deacetylase inhibition prevents cell death induced by loss of tricellular tight junction proteins in temperature-sensitive mouse cochlear cells
- (2017) Kenichi Takano et al. PLoS One
- SIRT3: Oncogene and Tumor Suppressor in Cancer
- (2017) Margalida Torrens-Mas et al. Cancers
- A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity
- (2016) Hui Jing et al. CANCER CELL
- SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b
- (2016) Sita Kugel et al. CELL
- MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents
- (2016) Kyogo Suzuki et al. JOURNAL OF CLINICAL ONCOLOGY
- Essential role of HDAC6 in the regulation of PD-L1 in melanoma
- (2016) M. Lienlaf et al. Molecular Oncology
- Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer
- (2016) A E Witt et al. ONCOGENE
- Histone Modifications and Cancer
- (2016) James E. Audia et al. Cold Spring Harbor Perspectives in Biology
- The interplay of epigenetic therapy and immunity in locally recurrent or metastatic estrogen receptor-positive breast cancer: Correlative analysis of ENCORE 301, a randomized, placebo-controlled phase II trial of exemestane with or without entinostat
- (2016) Yusuke Tomita et al. OncoImmunology
- Perspective on unraveling the versatility of ‘co-repressor’ complexes
- (2015) H. Irem Baymaz et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Nanoparticle formulations of histone deacetylase inhibitors for effective chemoradiotherapy in solid tumors
- (2015) Edina C. Wang et al. BIOMATERIALS
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- HDAC8 Inhibition Specifically Targets Inv(16) Acute Myeloid Leukemic Stem Cells by Restoring p53 Acetylation
- (2015) Jing Qi et al. Cell Stem Cell
- Histone Deacetylase 10 Regulates the Cell Cycle G2/M Phase Transition via a Novel Let-7–HMGA2–Cyclin A2 Pathway
- (2015) Yixuan Li et al. MOLECULAR AND CELLULAR BIOLOGY
- Dicer interacts with SIRT7 and regulates H3K18 deacetylation in response to DNA damaging agents
- (2015) Pei-Ying Zhang et al. NUCLEIC ACIDS RESEARCH
- SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors
- (2015) Shivani Malik et al. Scientific Reports
- The therapeutic promise of disrupting the PD-1/PD-L1 immune checkpoint in cancer: unleashing the CD8 T cell mediated anti-tumor activity results in significant, unprecedented clinical efficacy in various solid tumors
- (2015) Emanuela Romano et al. Journal for ImmunoTherapy of Cancer
- A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis
- (2014) S. Chen et al. BLOOD
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
- (2014) Katrina J. Falkenberg et al. NATURE REVIEWS DRUG DISCOVERY
- Histone deacetylase inhibitor (HDACI) mechanisms of action: Emerging insights
- (2014) Prithviraj Bose et al. PHARMACOLOGY & THERAPEUTICS
- Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
- (2014) K. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of Down-regulation of HDAC6 Expression on Proliferation, Cell Cycling and Migration of Esophageal Squamous Cell Carcinoma Cells and Related Molecular Mechanisms
- (2013) Ning Li et al. Asian Pacific Journal of Cancer Prevention
- SIRT5 desuccinylates and activates SOD1 to eliminate ROS
- (2013) Zhi-Feng Lin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Histone deacetylase 3 participates in self-renewal of liver cancer stem cells through histone modification
- (2013) Chungang Liu et al. CANCER LETTERS
- Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia
- (2013) I. Gojo et al. CLINICAL CANCER RESEARCH
- Disrupting Protein NEDDylation with MLN4924 Is a Novel Strategy to Target Cisplatin Resistance in Ovarian Cancer
- (2013) S. T. Nawrocki et al. CLINICAL CANCER RESEARCH
- Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors
- (2013) Michel D. Wissing et al. FASEB JOURNAL
- HDAC6 promotes hepatocellular carcinoma progression by inhibiting P53 transcriptional activity
- (2013) Gang Ding et al. FEBS LETTERS
- The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation
- (2013) L. Serrano et al. GENES & DEVELOPMENT
- SIRT3: As Simple As It Seems?
- (2013) David B. Lombard et al. GERONTOLOGY
- The Novel Chk1 Inhibitor MK-8776 Sensitizes Human Leukemia Cells to HDAC Inhibitors by Targeting the Intra-S Checkpoint and DNA Replication and Repair
- (2013) Y. Dai et al. MOLECULAR CANCER THERAPEUTICS
- A Core Chromatin Remodeling Factor Instructs Global Chromatin Signaling through Multivalent Reading of Nucleosome Codes
- (2013) Sujit S. Nair et al. MOLECULAR CELL
- Histone deacetylase 4 mediates SMAD family member 4 deacetylation and induces 5-fluorouracil resistance in breast cancer cells
- (2013) SEONG-LAN YU et al. ONCOLOGY REPORTS
- Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation
- (2012) Yuan-Yuan Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Elevation of c-FLIP in Castrate-Resistant Prostate Cancer Antagonizes Therapeutic Response to Androgen Receptor-Targeted Therapy
- (2012) C. McCourt et al. CLINICAL CANCER RESEARCH
- PLK1 Inhibitors Synergistically Potentiate HDAC Inhibitor Lethality in Imatinib Mesylate-Sensitive or -Resistant BCR/ABL+ Leukemia Cells In Vitro and In Vivo
- (2012) G. Dasmahapatra et al. CLINICAL CANCER RESEARCH
- HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL
- (2011) M. Kalac et al. BLOOD
- SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity
- (2011) Hyun-Seok Kim et al. CANCER CELL
- HDAC Inhibitors Potentiate the Activity of the BCR/ABL Kinase Inhibitor KW-2449 in Imatinib-Sensitive or -Resistant BCR/ABL+ Leukemia Cells In Vitro and In Vivo
- (2011) T. Nguyen et al. CLINICAL CANCER RESEARCH
- Suppression of lung cancer cell invasion and metastasis by connexin43 involves the secretion of follistatin-like 1 mediated via histone acetylation
- (2011) Wei Zhao et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF- B-dependent lymphoma
- (2010) M. A. Milhollen et al. BLOOD
- Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia
- (2010) R. T. Swords et al. BLOOD
- research paper: Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia
- (2010) Daniel Antunes Moreno et al. BRITISH JOURNAL OF HAEMATOLOGY
- Disruption of a Sirt1-Dependent Autophagy Checkpoint in the Prostate Results in Prostatic Intraepithelial Neoplasia Lesion Formation
- (2010) M. J. Powell et al. CANCER RESEARCH
- Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
- (2010) Sean J. Whittaker et al. JOURNAL OF CLINICAL ONCOLOGY
- RimJ is responsible for N α-acetylation of thymosin α1 in Escherichia coli
- (2009) Hongqing Fang et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- N-linked glycosylation in bacteria: an unexpected application
- (2009) Rebecca H Langdon et al. Future Microbiology
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
- (2009) Richard L. Piekarz et al. JOURNAL OF CLINICAL ONCOLOGY
- Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
- (2008) W Weichert et al. BRITISH JOURNAL OF CANCER
- Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant Mice
- (2008) Rui-Hong Wang et al. CANCER CELL
- Role of Acetylation and Extracellular Location of Heat Shock Protein 90 in Tumor Cell Invasion
- (2008) Y. Yang et al. CANCER RESEARCH
- The SIRT2 Deacetylase Regulates Autoacetylation of p300
- (2008) Joshua C. Black et al. MOLECULAR CELL
- The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance
- (2008) Alejandro Villagra et al. NATURE IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More